Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-FR Version v5-FR
Language French French
Date Updated 2018-10-11 2017-11-06
Drug Identification Number 02403633 02403633
Brand name TEVA-ALENDRONATE/CHOLECALCIFEROL TEVA-ALENDRONATE/CHOLECALCIFEROL
Common or Proper name ALENDRONATE VIT D ALENDRONATE VIT D
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients ALENDRONIC ACID VITAMIN D3 ALENDRONIC ACID VITAMIN D3
Strength(s) 70MG 2800UNIT 70MG 2800UNIT
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 4 4
ATC code M05BB M05BB
ATC description DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Reason for shortage Shortage of an active ingredient. Shortage of an active ingredient.
Anticipated start date
Actual start date 2017-10-30 2017-10-30
Estimated end date Unknown 2018-01-30
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments